Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

Autor: Thoralf Lange, K Machova Polakova, Enrico Gottardi, Tomasz Sacha, Nicholas C.P. Cross, Stéphanie Dulucq, Hans Ehrencrona, Fabrizio Pane, Letizia Foroni, Gisela Barbany, Rodica Talmaci, E. Oppliger Leibundgut, Andreas Hochhaus, Helen E. White, Martin C. Müller, Niels Pallisgaard, Barbara Izzo, Dolors Colomer, Giuseppe Saglio, Giovanni Martinelli, Thomas Lion

Publikováno v: Leukemia; 29(5), pp 999-1003 (2015)
Leukemia
Cross, N C P, White, H E, Colomer, D, Ehrencrona, H, Foroni, L, Gottardi, E, Lange, T, Lion, T, Polakova, K M, Dulucq, S, Martinelli, G, Leibundgut, E O, Pallisgaard, N, Barbany, G, Sacha, T, Talmaci, R, Izzo, B, Saglio, G, Pane, F, Muller, M C & Hochhaus, A 2015, ' Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia ', Leukemia, vol. 29, no. 5, pp. 999-1003 . https://doi.org/10.1038/leu.2015.29
Cross, N C P; White, H E; Colomer, D; Ehrencrona, H; Foroni, L; Gottardi, E; Lange, T; Lion, T; Machova Polakova, K; Dulucq, S; Martinelli, G; Oppliger Leibundgut, Elisabeth; Pallisgaard, N; Barbany, G; Sacha, T; Talmaci, R; Izzo, B; Saglio, G; Pane, F; Müller, M C; ... (2015). Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia, 29(5), pp. 999-1003. Nature Publishing Group 10.1038/leu.2015.29

Treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors has advanced to a stage where many patients achieve very low or undetectable levels of disease. Remarkably, some of these patients remain in sustained remission when treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::090442081ee84349b7dcc0f774bb673a
http://hdl.handle.net/11585/548720

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

Autor: S. Reading, Heike L. Pahl, Joop H. Jansen, Adam Ivey, Susanna Akiki, B.A. van der Reijden, N Maroc, M.J. Percy, E. Oppliger Leibundgut, K Tobal, Mary Frances McMullin, J. Bryon, David Grimwade, Albert Gruender, Tamara Alpermann, Niels Pallisgaard, A Bench, J J Kiladjian, Claire N. Harrison, Jelena V. Jovanovic, Nicholas C.P. Cross, Sally Jeffries, Paola Guglielmelli, G Nickless, Alessandro M. Vannucchi, Bridget S. Wilkins, T Barbui, Donal P. McLornan, Bruno Cassinat, Alessandro Pancrazzi, K Cuthill, Todd W. Kelley, Amy V. Jones, Sylvie Hermouet, K. Yeoman, Susanne Schnittger, S. Schwemmers, J. T. Prchal, Christine Chomienne, Eric Lippert

Publikováno v: Jovanovic, J V, Ivey, A, Vannucchi, A M, Lippert, E, Oppliger Leibundgut, E, Cassinat, B, Pallisgaard, N, Maroc, N, Hermouet, S, Nickless, G, Guglielmelli, P, van der Reijden, B A, Jansen, J H, Alpermann, T, Schnittger, S, Bench, A, Tobal, K, Wilkins, B, Cuthill, K, McLornan, D, Yeoman, K, Akiki, S, Bryon, J, Jeffries, S, Jones, A, Percy, M J, Schwemmers, S, Gruender, A, Kelley, T W, Reading, S, Pancrazzi, A, McMullin, M F, Pahl, H L, Cross, N C P, Harrison, C N, Prchal, J T, Chomienne, C, Kiladjian, J J, Barbui, T & Grimwade, D 2013, ' Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN &MPNr-EuroNet (COST action BM0902) study ', Leukemia, vol. 27, no. 10, pp. 2032-2039 . https://doi.org/10.1038/leu.2013.219

Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor disease response. However, there has been no consistent approach to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105dd652470953e772a177d47b59293c
https://pure.qub.ac.uk/en/publications/d05beb10-960c-4cca-8370-7f03728ddc47

Behandlung der chronischen myeloischen Leukämie 2007. Empfehlungen der Schweizerischen Arbeitsgruppe CML

Autor: U Hess, Stephan Dirnhofer, Gabriela M. Baerlocher, Urs Schanz, M Bergetzi, Alois Gratwohl, Michel A. Duchosal, Y Chalandon, E Oppliger Leibundgut, Jakob Passweg, M Gregor, Dominik Heim

Publikováno v: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::885918257007c16297f61faf746f8f19
https://doi.org/10.4414/smf.2007.06334